Shangtang Technology completed the placement of a number of international funds, long-term funds and existing shareholders of about HK$ 2.8 billion. For the news that Shang Tang announced today that it plans to place 1.865 billion shares and raise HK$ 2.787 billion, the reporter learned that a number of internationally renowned funds, long-term funds and existing shareholders will participate, and the funds raised will be used to support the company's core business development, including building an industry AI cloud, upgrading the scale of Shang Tang's large-scale devices, supporting generative artificial intelligence, including large-scale model research and product development, and (science and technology innovation board Daily)It is reported that Blackstone Group may withdraw from its bid for Bausch & Lomb, an eye care company. People familiar with the matter said that Blackstone Group may withdraw from its joint bid for Bausch & Lomb. Earlier, it was reported that Blackstone and TPG (Detai Capital) jointly bid for Bausch & Lomb, an eye care company. At present, negotiations are still in progress. If Bausch & Lomb is willing to accept a lower price, or TPG finds another private equity investment group as a trading partner, the transaction may still be completed.During the year, the enthusiasm of securities firms for issuing bonds was less than that of the same period last year. Adequate capital is an important condition for securities firms to develop innovative business, enhance market competitiveness and prevent risks. In order to supplement working capital and support business development, this year, brokers have raised more than 1.2 trillion yuan by issuing bonds. The data shows that since the beginning of this year, as of December 10th (according to the starting date of issuance), 67 securities firms have issued a total of 644 bonds, with the total amount of bonds issued reaching 1,224.727 billion yuan. On the whole, compared with the same period of last year, the number of bonds issued by brokers has dropped by 13.56% this year, and the total issuance has dropped by 13.58%. Zhu Keli, executive director of China Information Association, said, "Since the beginning of this year, the' enthusiasm' of securities companies to issue bonds is not as good as last year, which shows that securities companies are more cautious and calm in their attitude towards issuing bonds and actively respond to policy calls such as taking the road of capital-saving and high-quality development. In the future, brokers should further balance the development of light and heavy capital business, reasonably determine the scale and frequency of debt issuance financing, improve the efficiency of capital use and develop more steadily. " (Securities Daily)
Vietnam said that private equity giant KKR sought to expand its investment in the country. On the evening of December 10, the Vietnamese government website issued a statement saying that private equity investment company KKR was seeking to expand its investment opportunities in Vietnam. Su Lin, general secretary of the Central Committee of the Communist Party of Vietnam, expressed the hope that foreign investors, including American investors, will continue to increase their investment in Vietnam, especially in the fields of digital transformation, green transformation, renewable energy, clean energy and climate change. It is suggested that American enterprises, including KKR, continue to actively contribute to promoting bilateral cooperation, especially bilateral economic and scientific cooperation. David Petraeus, a partner of KKR, said that KKR is very optimistic about the investment prospects in Vietnam, and KKR Fund is looking for opportunities to expand cooperation and investment in Vietnam. He also promised to continue to support the development of Vietnam-US relations.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.The concept of humanoid robot fell by more than 10%, Sanfeng Intelligent fell by more than 10%, Eft and Wuzhou Spring fell by more than 8%, and many stocks such as Beite Technology, Mingzhi Electric and Shuanglin fell by more than 5%.
The first demonstration in China! Seiko Technology's high-performance PAN fiber technology has made key progress, and Seiko Technology's high-performance fiber precursor (polymerization process) "The first demonstration of safety and reliability of chemical process used in China" has successfully passed the evaluation of the expert group, which indicates that Seiko Technology's carbon fiber precursor preparation technology can be applied to industrialization on a large scale. On December 7th, Zhejiang Petroleum and Chemical Industry Association, entrusted by Zhejiang Emergency Management Department, organized and held the review meeting of "Demonstration of Safety and Reliability of Chemical Process Used for the First time in China" for high-performance PAN fiber in Hangzhou. Seiko Technology received a reply letter on December 10th.Ma Ying-jeou will lead the students of "Dajiu Academy" to visit the mainland. Xiao Xucen, CEO of Ma Ying-jeou Foundation, said today (11th) that Ma Ying-jeou will lead the students of "Dajiu Academy" to visit the mainland from December 18th to 26th at the invitation of the mainland. (Looking at the Taiwan Strait)It is reported that Blackstone Group may withdraw from its bid for Bausch & Lomb, an eye care company. People familiar with the matter said that Blackstone Group may withdraw from its joint bid for Bausch & Lomb. Earlier, it was reported that Blackstone and TPG (Detai Capital) jointly bid for Bausch & Lomb, an eye care company. At present, negotiations are still in progress. If Bausch & Lomb is willing to accept a lower price, or TPG finds another private equity investment group as a trading partner, the transaction may still be completed.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14